Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
Sabine Bachmaier
(2011) Journal of the American Chemical Society
The p16 status of tumor cell lines identifies small molecule inhibitors specific for cyclin-dependent kinase 4
100 μM) enhances nuclear TAZ localization in a dose-dependent manner and attenuates PPARγ-mediated adipocyte differentiation by facilitating PPARγ suppression activity of TAZ
CAS Number: 76376-43-7
(R)-SLV 319 703 Sabine BachmaierKi: 7. 8 and 7943 nM for CB1 and CB2 receptors, respectively by SLV 319 (R) SLV 319 is a CB1 receptor antagonist. Central cannabinoid (CB1) receptor antagonists can be used in the treatment of various diseases including cognitive disorders, neuroinflammatory disorders, obesity, septic shock, psychosis, addiction, as well as gastrointestinal disorders. In vitro: (R) SLV 319 is the inactive enantiomer of SLV 319 with 100 fold less affinity for the CB1
US$ 100.00
US$ 25.00
US$ 169.95
US$ 31.99
US$ 112.50
US$ 191.50